Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.

about

Capsaicin-loaded nanolipoidal carriers for topical application: design, characterization, and in vitro/in vivo evaluation.

P2860

Q33734460-C0F045E9-9636-40A6-AE42-388E5A65DBF7

P2860

Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.

Item

http://www.wikidata.org/entity/Q53054958

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Sustained release of piroxicam ...... ammatory therapeutics in vivo.

@en

Sustained release of piroxicam ...... ammatory therapeutics in vivo.

@nl

type

Item

label

Sustained release of piroxicam ...... ammatory therapeutics in vivo.

@en

Sustained release of piroxicam ...... ammatory therapeutics in vivo.

@nl

prefLabel

Sustained release of piroxicam ...... ammatory therapeutics in vivo.

@en

Sustained release of piroxicam ...... ammatory therapeutics in vivo.

@nl

P1476

Sustained release of piroxicam ...... ammatory therapeutics in vivo.

@en

P2093

Jian-Qing Gao

http://www.w3.org/2001/XMLSchema#string

Li-Hua Peng

http://www.w3.org/2001/XMLSchema#string

Lian Yu

http://www.w3.org/2001/XMLSchema#string

Wei Wei

http://www.w3.org/2001/XMLSchema#string

Yee-Song Chong

http://www.w3.org/2001/XMLSchema#string

Ying-Hui Shan

http://www.w3.org/2001/XMLSchema#string

P2860

Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1

Current status and future potential of transdermal drug delivery

A physical mechanism to explain the delivery of chemical penetration enhancers into skin during transdermal sonophoresis - Insight into the observed synergism

Influence of vehicle resistance on transdermal iontophoretic delivery of acetylcholine and sodium nitroprusside in humans.

Iontophoresis: a potential emergence of a transdermal drug delivery system.

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.

Apolipoprotein A-I attenuates ovalbumin-induced neutrophilic airway inflammation via a granulocyte colony-stimulating factor-dependent mechanism.

Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion

NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes.

Topical ocular delivery of NSAIDs.

P304

55-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/03639045.2016.1220563

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27498809

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.

about

P2860

P2860

Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921